Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOACT endovascular thrombolysis in severe cerebral venous thrombosis
2010-020302-15Phase 3Terminated
- Sponsor
- Instituto de Medicina Molecular João Lobo Antunes
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of tissue-plasminogen activator in cerebral sinovenous thrombosis (CSVT), sponsored by Instituto de Medicina Molecular João Lobo Antunes. Primary endpoint: Functional outcome at 12 months. Started Aug 2011; status: terminated.
02
Drugs
tissue-plasminogen activator
03
Conditions
cerebral sinovenous thrombosis (CSVT)
Beyond the preview
Go deeper on 2010-020302-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020302-15.